Katalin Tóth

948 total citations
44 papers, 540 citations indexed

About

Katalin Tóth is a scholar working on Pharmacology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Katalin Tóth has authored 44 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 9 papers in Oncology and 8 papers in Psychiatry and Mental health. Recurrent topics in Katalin Tóth's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Katalin Tóth is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Katalin Tóth collaborates with scholars based in Hungary, United States and Slovenia. Katalin Tóth's co-authors include Katalin Monostory, Ádám Kiss, Gábor Csukly, Andrea Nagy, Judit Kralovánszky, András Jeney, István Bitter, András Rosta, Laśzló Kob́ori and Miklós Garami and has published in prestigious journals such as Cell, Scientific Reports and Epilepsia.

In The Last Decade

Katalin Tóth

42 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katalin Tóth Hungary 15 145 143 123 112 101 44 540
Raja Venkatasubramanian United States 14 140 1.0× 200 1.4× 119 1.0× 198 1.8× 111 1.1× 20 720
Gina Mejía‐Abril Spain 15 105 0.7× 128 0.9× 259 2.1× 108 1.0× 123 1.2× 49 647
Carmen Belmonte Spain 14 118 0.8× 111 0.8× 188 1.5× 84 0.8× 47 0.5× 21 455
Bernard Esquivel United States 5 60 0.4× 76 0.5× 136 1.1× 69 0.6× 88 0.9× 8 467
Ádám Kiss Hungary 12 136 0.9× 120 0.8× 116 0.9× 53 0.5× 47 0.5× 19 328
Tamara Božina Croatia 12 67 0.5× 74 0.5× 75 0.6× 65 0.6× 57 0.6× 34 312
Monique Schmitt Switzerland 11 117 0.8× 61 0.4× 113 0.9× 83 0.7× 109 1.1× 23 607
Ali R. Saadatmand Germany 10 48 0.3× 184 1.3× 68 0.6× 245 2.2× 103 1.0× 12 501
Pablo Zubiaur Spain 17 171 1.2× 164 1.1× 332 2.7× 130 1.2× 161 1.6× 73 877
E. Baltes Belgium 12 242 1.7× 364 2.5× 76 0.6× 111 1.0× 84 0.8× 15 792

Countries citing papers authored by Katalin Tóth

Since Specialization
Citations

This map shows the geographic impact of Katalin Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katalin Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katalin Tóth more than expected).

Fields of papers citing papers by Katalin Tóth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katalin Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katalin Tóth. The network helps show where Katalin Tóth may publish in the future.

Co-authorship network of co-authors of Katalin Tóth

This figure shows the co-authorship network connecting the top 25 collaborators of Katalin Tóth. A scholar is included among the top collaborators of Katalin Tóth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katalin Tóth. Katalin Tóth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tóth, Katalin, et al.. (2023). Ki mit visz át a túlsó partra?. 33(3). 16–34.
2.
Tóth, Katalin, et al.. (2023). Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments. International Journal for Parasitology Drugs and Drug Resistance. 21. 65–73. 3 indexed citations
3.
Tóth, Katalin, et al.. (2023). CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients. Scientific Reports. 13(1). 18507–18507. 11 indexed citations
4.
Pryce, Kerri D., Hye Jin Kang, Farhana Sakloth, et al.. (2021). A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects. Neuropharmacology. 195. 108673–108673. 22 indexed citations
5.
Kiss, Ádám, et al.. (2020). End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s. Pharmacological Reports. 72(6). 1695–1705. 14 indexed citations
6.
Kiss, Ádám, et al.. (2020). Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia. Scientific Reports. 10(1). 21283–21283. 15 indexed citations
7.
Kiss, Ádám, et al.. (2019). Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure. European Archives of Psychiatry and Clinical Neuroscience. 270(1). 71–82. 19 indexed citations
8.
Monostory, Katalin, et al.. (2018). Relevance of CYP2C9 Function in Valproate Therapy. Current Neuropharmacology. 17(1). 99–106. 33 indexed citations
9.
Kiss, Ádám, et al.. (2017). Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction. Pharmacological Reports. 70(3). 525–532. 20 indexed citations
10.
Tóth, Katalin, et al.. (2017). Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics. The International Journal of Neuropsychopharmacology. 20(7). 529–537. 37 indexed citations
11.
12.
Váczi, Márk, Szilvia Anett Nagy, Tamás Kőszegi, et al.. (2014). Mechanical, hormonal, and hypertrophic adaptations to 10weeks of eccentric and stretch-shortening cycle exercise training in old males. Experimental Gerontology. 58. 69–77. 33 indexed citations
13.
Tóth, Katalin, Radim Vrzal, Erika Orbán, et al.. (2013). Dehydroepiandrosterone post-transcriptionally modifies CYP1A2 induction involving androgen receptor. Chemico-Biological Interactions. 203(3). 597–603. 2 indexed citations
14.
15.
Nagy, Zsolt B., et al.. (2010). Current concepts in the genetic diagnostics of rheumatoid arthritis. Expert Review of Molecular Diagnostics. 10(5). 603–618. 6 indexed citations
16.
Doró, Péter, et al.. (2005). Utilization of oral antihyperglycemic drugs over a 7–year period (1998–2004) in a Hungarian population and adherence to drug therapy. European Journal of Clinical Pharmacology. 61(12). 893–897. 29 indexed citations
17.
Komlósi, Katalin, Judit Bene, Manju Ghosh, et al.. (2003). Search for Factor V Arg<sup>306</sup> Cambridge and Hong Kong Mutations in Mixed Hungarian Population Samples. Acta Haematologica. 110(4). 220–222. 2 indexed citations
18.
19.
Kralovánszky, Judit, et al.. (1998). Putative Role of Dihydropyrimidine Dehydrogenase in the Toxic Side Effect of 5-Fluorouracil in Colorectal Cancer Patients. Oncology. 55(5). 468–474. 49 indexed citations
20.
Regöly‐Mérei, Andrea, et al.. (1989). Subacute toxicological examination of Dithane M-45. Food and Chemical Toxicology. 27(8). 531–538. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raja Venkatasubramanian Breakdown of academic impact, for papers by Gina Mejía‐Abril Breakdown of academic impact, for papers by Carmen Belmonte Breakdown of academic impact, for papers by Bernard Esquivel Breakdown of academic impact, for papers by Ádám Kiss Breakdown of academic impact, for papers by Tamara Božina Breakdown of academic impact, for papers by Monique Schmitt Breakdown of academic impact, for papers by Ali R. Saadatmand Breakdown of academic impact, for papers by Pablo Zubiaur Breakdown of academic impact, for papers by E. Baltes
Rankless by CCL
2026